Pep-20 has been shown to inhibit melanoma growth in subcutaneous tumor-bearing mice by significantly increasing macrophage-mediated phagocytosis and stimulating the population of intertumoral CD8+ T cells and the secretion of IFN-γ. Here, CD8A is linked to neoplasm.